Concepedia

Yun Chon

YC

Statistics

Publications

37

Citations

4K

H-Index

24

Active since

1994

Affiliations

Amgen (United States)(Current)

International Vaccine Institute

University of California, Los Angeles

University of Cambridge

University of Wisconsin–Madison

Yun Chon is an author at Amgen (United States) specializing in medicine, allergy, and asthma.

ORCID

Top concepts

Publications per year

1994–2025

37

Publications

37

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma

William W. Busse, Stephen T. Holgate, Edward Kerwin et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 649 citations

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease

Stephan R. Targan, Brian G. Feagan, Séverine Vermeire et al. · The American Journal of Gastroenterology · 2016 · 360 citations

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Hong Sun, David W. Dodick, Stephen D. Silberstein et al. · The Lancet Neurology · 2016 · 357 citations

, , +5

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

William G. Goodman, Jorge A. Ramirez, Thomas R. Belin et al. · Kidney International · 1994 · 318 citations

, , +8

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

Daniel J. Lovell, Andreas Reiff, Norman T. Ilowite et al. · Arthritis & Rheumatism · 2008 · 317 citations

Rows per page

1–5 of 37